GlassScriptPhysician profile
Mohamed Macki
NPI 1841600590
$14,084.56
in general payments reported to CMS, 2019-2025
12 companies · $2,666 in 2025
The $2,666 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $187 · 2022: $2,724 · 2023: $4,587 · 2024: $3,920 · 2025: $2,666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,800 · Food and Beverage: $4,373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,799.97 |
| Food and Beverage | $4,373.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $6,225.10 | 2022-2025 | Caliber, Xlif, Excelsius Gps |
| Stryker Corporation | $3,707.34 | 2022-2025 | Cascadia Interbody System, Everest Spinal System, Capri Corpectomy Cage System |
| Medtronic, INC. | $1,762.11 | 2022-2024 | Unid_pass |
| Nuvasive, INC. | $986.08 | 2022-2023 | Simplify Cervical Artificial Disc, Xlif, Plif |
| Si-Bone, INC. | $434.67 | 2021-2022 | |
| Bioventus LLC | $364.65 | 2025 | Bonescalpel & Sonicone (O.R.) |
| Pacira Pharmaceuticals Incorporated | $165.23 | 2023 | Exparel, Iovera |
| Abbott Laboratories | $135.15 | 2024 | Proclaim |
| Centinel Spine, LLC | $117.44 | 2023 | Prodisc L |
| Cerapedics INC. | $96.00 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Sanara Medtech INC. | $54.53 | 2022 | |
| Orthofix Medical, INC. | $36.26 | 2025 | Cervical-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohamed Macki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.